Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease.

ABSTRACT:

Importance

Patients with abdominal aortic aneurysm have a high risk of ischemic events associated with concomitant atherosclerotic cardiovascular disease, and current clinical practice guidelines recommend antiplatelet therapy to mitigate this risk. However, in patients with aneurysms without symptomatic atherosclerosis, the benefit of antiplatelet therapy has been sparsely investigated.

Objective

To estimate the effect of antiplatelets on the risk of ischemic events and bleeding in individuals with abdominal aneurysms with no symptomatic atherosclerotic vascular disease.

Design, setting, and participants

A comparative effectiveness research study using a target trial emulation framework was performed. Population-based, cross-linked observational data from Danish nati

SUBMITTER: Nicolajsen CW 

PROVIDER: S-EPMC10600585 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature